Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7300
-0.0100 (-1.35%)
Jun 1, 2026, 4:08 PM HKT
Market Cap630.43M -23.2%
Revenue (ttm)1.93B -21.6%
Net Income19.24M -81.8%
EPS0.02 -81.8%
Shares Out 863.60M
PE Ratio32.80
Forward PEn/a
Dividend0.05 (6.85%)
Ex-Dividend DateMay 23, 2025
Volume528,000
Open0.7100
Previous Close0.7400
Day's Range0.6800 - 0.7500
52-Week Range0.5000 - 0.9800
Beta0.40
Analystsn/a
Price Targetn/a
Earnings DateJun 2, 2026

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through two segments Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing and property management... [Read more]

Sector Healthcare
Founded 1993
Employees 2,284
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3737
Full Company Profile

Financial Performance

In 2025, HKG:3737's revenue was 1.74 billion, a decrease of -21.55% compared to the previous year's 2.21 billion. Earnings were 17.29 million, a decrease of -81.84%.

Financial numbers in CNY Financial Statements